Fu Rui, Sekercioglu Nigar, Mathur Maya B, Couban Rachel, Coyte Peter C
Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Kidney Med. 2020 Dec 3;3(1):64-75.e1. doi: 10.1016/j.xkme.2020.09.013. eCollection 2021 Jan-Feb.
RATIONALE & OBJECTIVES: Due to unmeasured confounding, observational studies have limitations when assessing whether dialysis initiation reduces mortality compared with conservative therapy among adults with advanced chronic kidney disease (CKD). We addressed this issue in this meta-analysis.
Meta-analysis with bias analysis for unmeasured confounding.
SETTING & STUDY POPULATION: Adults with stage 4 or 5 CKD who had initiated dialysis or conservative treatment.
Prospective or retrospective cohort studies comparing survival of dialysis versus conservatively managed patients were searched on MEDLINE and Embase from January 2009 to March 20, 2019.
HRs of all-cause mortality associated with dialysis initiation compared with conservative treatment.
We pooled HRs using a random-effects model. We estimated the percentage of effect sizes more protective than HRs of 0.80 and severity of unmeasured confounding that could reduce this percentage to only 10%. Subgroup analysis was performed for studies with only older patients (aged ≥ 65 years).
12 studies were included that involved 16,609 dialysis patients and 3,691 conservatively managed patients. A random-effects model suggested that dialysis initiation was associated with a mean mortality HR of 0.47 (95% CI, 0.34-0.64), in which 92% (95% CI, 50%-100%) of the true effects were more protective than HRs of 0.80. To reduce the percentage of HRs < 0.80 to 10%, unmeasured confounder(s) would need to be associated with both dialysis initiation and mortality by relative risks of 4.05 (95% CI, 2.39-4.15), which is equivalent to shifting each study's estimated HR by 2.31-fold (95% CI, 1.51-2.36). Restricting studies to include only older patients did not modify the results.
Limited number of studies and evidence on the absence of publication bias.
Our findings suggest that dialysis initiation considerably reduces mortality among adults with advanced CKD. Future bias-adjusted meta-analyses need to assess outcomes beyond mortality.
由于存在未测量的混杂因素,在评估晚期慢性肾脏病(CKD)成人患者中,与保守治疗相比,开始透析是否能降低死亡率时,观察性研究存在局限性。我们在这项荟萃分析中解决了这个问题。
进行荟萃分析并对未测量的混杂因素进行偏倚分析。
已开始透析或接受保守治疗的4期或5期CKD成人患者。
在2009年1月至2019年3月20日期间,在MEDLINE和Embase数据库中检索比较透析患者与保守治疗患者生存率的前瞻性或回顾性队列研究。
与开始透析相比,保守治疗的全因死亡率的风险比(HRs)。
我们使用随机效应模型汇总HRs。我们估计了比HR为0.80更具保护作用的效应量百分比,以及可能将该百分比降至仅10%的未测量混杂因素的严重程度。对仅纳入老年患者(年龄≥65岁)的研究进行亚组分析。
纳入了12项研究,涉及16609例透析患者和3691例接受保守治疗的患者。随机效应模型表明,开始透析与平均死亡率HR为0.47(95%CI,0.34 - 0.64)相关,其中92%(95%CI,50% - 100%)的真实效应比HR为0.80更具保护作用。为了将HR<0.80的百分比降至10%,未测量的混杂因素需要与开始透析和死亡率均相关,相对风险为4.05(95%CI,2.39 - 4.15),这相当于将每项研究估计的HR改变2.31倍(95%CI,1.51 - 2.36)。将研究限制为仅纳入老年患者并未改变结果。
研究数量有限且缺乏发表偏倚的证据。
我们的研究结果表明,开始透析可显著降低晚期CKD成人患者的死亡率。未来经过偏倚调整的荟萃分析需要评估死亡率以外的结局。